Causes of variability in listing and access to liver transplantation for critically ill patients with cirrhosis: Acknowledging the elephant in the room
Thierry Artzner, Luca Belli, François Faitot, Rajiv Jalan – 12 August 2022
Novel approaches are needed to study social determinants of health in liver transplantation
Jin Ge, Jennifer C. Lai, Sharad I. Wadhwani – 12 August 2022
Low‐dose aspirin, rejection, and thrombosis: Is it the Wonder Drug® of liver transplantation?
Grace S. Lee‐Riddle, Juan P. Rocca – 11 August 2022
Letter to the editor: HCC EV ECG score: An extracellular vesicle–based protein assay for detection of early‐stage HCC
Wenhao Luo, Yu Gu, Taiping Zhang – 11 August 2022
Liver allocation policies for hepatocellular carcinoma have leveled the playing field—But who should be playing?
Allison J. Kwong, Neil Mehta – 11 August 2022
Reply
Yi‐Te Lee, Yazhen Zhu, Ju Dong Yang, Vatche G. Agopian, Hsian‐Rong Tseng – 10 August 2022
Reply
Laurens A. Kleef, Milan J. Sonneveld, Robert J. Knegt – 10 August 2022
Fibroblasts to hepatocytes: A nonstop flight into cell therapy for liver diseases?
Valerie Gouon‐Evans, Romina Fiorotto – 10 August 2022
Letter to the editor: Screening for fatty liver disease and fibrosis in the elderly population: A call for action
Jie Li, Mindie H. Nguyen – 10 August 2022
Reply
Laurens A. Kleef, Milan J. Sonneveld, Robert J. Knegt – 10 August 2022